Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/166643
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCastañeda, Santos-
dc.contributor.authorMartín Martínez, María A.-
dc.contributor.authorGonzález Juanatey, Carlos-
dc.contributor.authorLlorca Díaz, Javier-
dc.contributor.authorGarcía Yébenes, María J.-
dc.contributor.authorPérez Vicente, Sabina-
dc.contributor.authorSánchez Costa, Jesús T.-
dc.contributor.authorDíaz Gonzalez, Federico-
dc.contributor.authorGonzález Gay, Miguel A.-
dc.contributor.authorNolla Solé, Joan Miquel-
dc.contributor.authorCARMA Project Collaborative Group-
dc.date.accessioned2020-06-25T19:06:55Z-
dc.date.available2020-06-25T19:06:55Z-
dc.date.issued2015-06-01-
dc.identifier.issn0049-0172-
dc.identifier.urihttp://hdl.handle.net/2445/166643-
dc.description.abstractObjective: To establish the cardiovascular (CV) morbidity and associated risk factors for CV disease (CVD) in Spanish patients with chronic inflammatory rheumatic diseases (CIRD) and unexposed individuals attending rheumatology clinics. Methods: Analysis of data from the baseline visit of a 10-year prospective study [CARdiovascular in rheuMAtology (CARMA) project] that includes a cohort of patients with CIRD [rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA)] and another cohort of matched individuals without CIRD attending outpatient rheumatology clinics from 67 hospitals in Spain. Prevalence of CV morbidity, CV risk factors, and systematic coronary risk evaluation (SCORE) assessment were analyzed. Results: A total of 2234 patients (775 RA, 738 AS, and 721 PsA) and 677 unexposed subjects were included. Patients had low disease activity at the time of recruitment. PsA patients had more commonly classic CV risk factors and metabolic syndrome features than did the remaining individuals. The prevalence of CVD was higher in RA (10.5%) than in AS (7.6%), PsA (7.2%), and unexposed individuals (6.4%). A multivariate analysis adjusted for the presence of classic CV risk factors and disease duration revealed a positive trend for CVD in RA (OR = 1.58; 95% CI: 0.90-2.76; p = 0.10) and AS (OR = 1.77; 95% CI: 0.96-3.27; p = 0.07). Disease duration in all CIRD groups and functional capacity (HAQ) in RA were associated with an increased risk of CVD (OR = 2.15; 95% CI: 1.29-3.56; p = 0.003). Most patients had a moderate CV risk according to the SCORE charts. Conclusions: Despite recent advances in the management of CIRD, incidence of CVD remains increased in Spanish subjects with CIRD attending outpatient rheumatology clinics.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier-
dc.relation.isformatofReproducció del document publicat a:-
dc.relation.ispartofSeminars in Arthritis and Rheumatism, 2015, vol. 44, p. 618-626-
dc.rightscc-by-nc-nd (c) Elsevier, 2015-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationMalalties cardiovasculars-
dc.subject.classificationArtritis reumatoide-
dc.subject.classificationReumatologia-
dc.subject.classificationMorbiditat-
dc.subject.classificationEspanya-
dc.subject.otherCardiovascular diseases-
dc.subject.otherRheumatoid arthritis-
dc.subject.otherRheumatology-
dc.subject.otherMorbidity-
dc.subject.otherSpain-
dc.titleCardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attendingrheumatology clinics: Baseline data of the CARMA Project-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec654768-
dc.date.updated2020-06-25T19:06:55Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
654768.pdf654.35 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons